Patent · US Active

Diagnosis and monitoring of liver disease

US11028425B2 · kind B2 · utility

1Cited by
7References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2019
Grant dateJun 8, 2021
Priority date
Expiry dateMar 15, 2039

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/56
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Methods and compositions for screening or diagnosis of liver disease are provided. The results may also indicate course and efficacy of treatment. The composition includes an activity sensor and a reporter releasably attached to the activity sensor. The method includes detecting the presence and/or amount of a reporter. The reporter is released from an activity sensor in the presence of diseased liver tissue but remains attached to the activity sensor in healthy tissue. The presence and/or amount of the reporter are used to characterize the liver disease. The liver disease may be nonalcoholic steatohepatitis (NASH) and results may further indicate staging of NASH.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.